The new DOC has been good to its word. And knowing that we are now brining in more cash than is going out is awesome news. After all, you cant give guidance that DOC will be EBITDA positive if there hasn't been two good months out of the three.
The 5-10% revenue growth guidance is somewhat disappointing but still heading in the right direction. This probably indicates that consultations have gone backwards. However, now that a sustainable base has been formed, DOC can once again look at growth opportunity which will add to profitability.
Overall, if we had no information over the past year and this report came out - we would be super happy.
DOC Price at posting:
6.3¢ Sentiment: Buy Disclosure: Held
